ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions

All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z

Abstract Number: 2976

Gamma secretase dependent tryptophan-kynurenine pathway alterations in hidradenitis suppurativa
Abstract Number: 2251

Gap in HPV Vaccine Uptake Contributing to Cervical Health Disparities in Women with Systemic Lupus Erythematosus
Abstract Number: 1783

Gaps in Glucocorticoid-Induced Osteoporosis Prevention in Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort (CATCH)
Abstract Number: 2781

Gastrointestinal Adverse Events in Rheumatic Disease Patients Treated With TNF-α Inhibitors Versus IL-17 Inhibitors: Evidence from a Propensity-Matched Retrospective Study
Abstract Number: 0235

Gastrointestinal Symptoms in Limited versus Diffuse Systemic Sclerosis: A Single Center Study
Abstract Number: 1509

Gender differences in clinical patterns in juvenile systemic sclerosis: updates from the Juvenile Scleroderma Inception Cohort
Abstract Number: 0105

Gene expression signatures as predictors of response to methotrexate in pediatric non-infectious uveitis (NIU).
Abstract Number: 0029

Generation, Viability Assessment and Fibrotic Transformation of a Novel Organotypic Model for Cutaneous Fibrosis: Basis for Therapeutic Optimization in Systemic Sclerosis
Abstract Number: 1444

Genes and genetic variants associated with non-response to multiple targeted therapies in rheumatoid arthritis: an analysis using whole genome sequencing data
Abstract Number: 1990

Genetic Dissociation of Type I and Type II Interferon Signaling Reveals an Antifibrotic Role for IFNγ and Establishes a Murine Model of Progressive Lupus Nephritis Fibrosis
Abstract Number: 0030

Genetic prediction of systemic sclerosis and its subphenotypes using joint HLA and polygenic risk score models
Abstract Number: 0130

Genetic Predisposition to Leukopenia in Patients with Rheumatoid Arthritis
Abstract Number: 1019

Genetic predisposition to Systemic Lupus Erythematosus increases Decoy receptor 3 levels, which associate with disease severity and progression
Abstract Number: 0486

Genetic Risk for Pain for the Prediction of Low Disease Activity with Methotrexate Compared to A Clinical-Pharmacogenetic Score in Rheumatoid Arthritis
Abstract Number: 2937

Genetic test utilization in adult patients with suspected inborn errors of immunity presenting with rheumatic and musculoskeletal disease: A retrospective single-center study
Abstract Number: 2751

Genetically Predicted Placental Gene Expression Signals Associated with Systemic Lupus Erythematosus Risk
Abstract Number: 0570

Genetics of juvenile SLE in India: Next Generation Sequencing identifies novel and founder variants associated with severe disease and mortality.
Abstract Number: 0571

Genomics in Enthesitis Related Arthritis (ERA) patients. A first step in understanding the association between genetic biomarkers and clinical data among ERA patients
Abstract Number: 1747

Geographic and Demographic Disparities in Psoriasis Burden in the United States, 1990-2023: A Global Burden of Disease Analysis
Abstract Number: 2707

Geographic and Socioeconomic Disparities in Access to Pediatric Rheumatology Care
Abstract Number: 0236

Geographic and Temporal Trends in Systemic Sclerosis Mortality: A CDC WONDER Joinpoint Analysis of End-of-Life Care Settings (2018-2024)
Abstract Number: 0814

Geographic, Demographic, And Metabolic Disparities In Gout Burden In The United States: A Global Burden Of Disease 2023 Study
Abstract Number: 1944

Giant Cell Arteritis Arterial Single Nucleus RNA Sequencing Reveals IFN-γ-Enriched Myeloid Activation and Fibroinflammatory Remodeling of the Vessel Wall
Abstract Number: 0172

Giant Cell Arteritis with Normal C-Reactive Protein: Clinical Characteristics, Outcomes, and Response to Tocilizumab (the CANON study)
Abstract Number: 1380

Gland-specific color Doppler activity in Sjögren’s disease: associations with disease activity, patient-reported outcomes and objective glandular function
Abstract Number: 2401

Global Cardiovascular Safety of Romosozumab in Patients With Rheumatoid Arthritis and Osteoporosis: A Propensity-Matched TriNetX Cohort Study
Abstract Number: 1922

Global, Regional, and National Burden of Osteoarthritis, 1990-2023, with Forecasts to 2050: A Global Burden of Disease Study 2023 Analysis
Abstract Number: 2866

GLP-1 Agonist Use and Outcomes in Connective Tissue Disease-Associated Interstitial Lung Disease
Abstract Number: 0361

GLP-1 Receptor Agonist Eligibility and Uptake and their relation with Psoriatic Arthritis Disease Activity and Cardiovascular Morbidity: Real-World Data from a Cardio-Rheumatology Cohort
Abstract Number: 1898

GLP-1 receptor agonist for primary prevention of DMARD-associated malignancy in patients with Rheumatoid Arthritis taking DMARDs: A multi-center real-world analysis
Abstract Number: 1343

GLP-1 Receptor Agonist Therapy Gap and Metabolic Syndrome Burden in U.S. Adults With Psoriatic Arthritis: A Nationally Representative Cross-Sectional Analysis
Abstract Number: 0173

GLP-1 Receptor Agonist Use Is Associated with Reduced Major Adverse Cardiovascular Events in Patients with Giant Cell Arteritis: A Retrospective Cohort Study Using the TriNetX Database
Abstract Number: 1445

GLP-1 Receptor Agonists and Pulmonary Outcomes in Rheumatoid Arthritis: A Propensity Score-Matched Retrospective Cohort Study
Abstract Number: 1315

GLP-1 Receptor Agonists in PsA: Evolving US Rheumatologist Use and Perceptions Across a Changing Evidence Landscape
Abstract Number: 1784

GLP-1 Receptor Agonists Reduce Composite Cardiovascular and Mortality Outcomes in Veterans with Rheumatologic Diseases: A National Propensity-Matched Cohort Study
Abstract Number: 0711

Glucagon-like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Eligibility Among US Adults with Gout: A General Population Study
Abstract Number: 2626

Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Based Therapies and Obesity-Associated Treatment Response in Inflammatory Arthritis: A Scoping Review
Abstract Number: 2206

Glucocorticoid Dose Reduction and Low Flare Rates in Patients with SLE Receiving Anifrolumab in Routine Practice: 12-Month Interim Analysis of a Multinational Observational Real-World Study
Abstract Number: 1594

Glucocorticoid Tapering to ≤5 mg/day in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Real-World Patterns and Safety Signals from An Italian-Taiwanese Collaborative Study
Abstract Number: 1156

Glucocorticoid-Associated Conditions in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis With Prolonged Moderate-to-High Dose Glucocorticoid Use
Abstract Number: 2207

Glucocorticoid-Sparing Maintenance of Disease Control in Patients with Systemic Lupus Erythematosus: 48-Week Results from a Phase 3 Trial of Dapirolizumab Pegol
Abstract Number: 2252

Glucose-6-phosphate dehydrogenase (G6PD) mutations predispose to autoantibody production, cytokine abnormalities, leukopenia, nephritis, and neurobehavioral manifestations in systemic lupus erythematosus (SLE)
Abstract Number: 0237

Glycosylation Patterns as Biomarkers and Mechanistic Contributors to Disease Progression in VEDOSS and Systemic Sclerosis
Abstract Number: 0712

Gout Flare Burden and Cardiorenal Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus and Gout: A Propensity-Matched Retrospective Study
Abstract Number: 0713

Gout in Advanced Chronic Kidney Disease: High Prevalence, Low Target Attainment, and Association with Mortality – Real-World Evidence for a Complex Comorbidity
Abstract Number: 2136

Graded, MPO/p-ANCA-selective co-activation of cell-bound complement and T-cell autoantibodies with ANCA intensity
Abstract Number: 1865

Graft Failure among Kidney Transplant Recipients with End-Stage Kidney Disease Attributed to Systemic Lupus Erythematosus vs. Other Immune-Mediated Diseases
Abstract Number: 0846

Granulocyte and Monocyte Apheresis with Adacolumn in Rheumatic Diseases: A Systematic Review of the Available Evidence
Abstract Number: 1999

Granzyme B Expression Is Associated with Perforin-2 Expression and TNFα Signaling in Plasmacytoid Dendritic Cells in Cutaneous Lupus Erythematosus
Abstract Number: 1748

Greater Skin Disease Activity Is Associated with Worse Work Productivity
Abstract Number: 1801

Grip Strength and Muscle Mass Dissociation: Prevalence and Clinical Factors Associated with Dynapenia in Rheumatic Diseases
Abstract Number: 1446

Grip Strength Measured by Smartphone-Connected Dynamometer Correlates with Disease Activity in Inflammatory Arthritis: Implications for Remote Patient Monitoring
Abstract Number: 2331

Group-level Stability in Coping Use Masks Individual Changes in Axial Spondyloarthritis: a longitudinal analysis
Abstract Number: 1447

Growth Differentiation Factor 15 Predicts Heart Failure Development in Rheumatoid Arthritis
Abstract Number: 0145

GT802, a Dual CD19/BCMA mRNA In Vivo CAR-T Therapy, Targets B and Plasma Cells Through In Vivo T-Cell Reprogramming
Abstract Number: 2295

Guselkumab Efficacy on Improvements in American College of Rheumatology Response Components and Association With Structural Damage Progression in Participants With Active and Erosive Psoriatic Arthritis: Results From a Phase 3b, Randomized Double-Blind, Placebo-Controlled Study
Abstract Number: 1316

Guselkumab Response and Inhibition of Structural Damage Progression in Active Psoriatic Arthritis Across APEX Participant Subgroups
Abstract Number: 1032

Gut Metagenomic and PhIP-seq Profiles Link Microbial Functions to Antibody Remodeling in PsA
Abstract Number: 1189

Gut Microbiome and Metabolomic Signatures of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease: Insights from an International Cohort
Abstract Number: 0487

Gut Microbiome Signatures Moderately Predict Rheumatoid Arthritis Status Using Genus-Level Machine Learning Models
Abstract Number: 2820

Gut-to-Joint Cellular Trafficking in Early Osteoarthritis: Photoconversion-Based Tracking Reveals Mucosal-Origin Cell Enrichment in Synovial Tissue
Abstract Number: 2974

GW4869 reduces UVB-induced keratinocyte-derived extracellular vesicle release, EV-associated cGAS, and EV-mediated pro-inflammatory responses in macrophages
Abstract Number: 0959

GZMK+ CD8+ T Cells Drive Neutrophil Extracellular Trap Formation in ANCA-Associated Glomerulonephritis

All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z